6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine
C24H28FN5OS — CID 155728761
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine
6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine (PubChem CID 155728761) has the molecular formula C24H28FN5OS and a molecular weight of 453.59 g/mol. Its IUPAC name is 6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine.
Molecular Properties
| Compound Name | 6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine |
|---|---|
| PubChem CID | 155728761 |
| Molecular Formula | C24H28FN5OS |
| Molecular Weight | 453.59 g/mol |
| Exact Mass | 453.20 |
| IUPAC Name | 6-(5-fluoropyrimidin-2-yl)-8-methoxy-N-[(E)-3-[(Z)-pent-2-en-2-yl]sulfanylhex-3-en-2-yl]quinazolin-4-amine |
| SMILES | CC/C=C(/C)S/C(=C/CC)C(C)Nc1ncnc2c(OC)cc(-c3ncc(F)cn3)cc12 |
| InChI | InChI=1S/C24H28FN5OS/c1-6-8-15(3)32-21(9-7-2)16(4)30-24-19-10-17(23-26-12-18(25)13-27-23)11-20(31-5)22(19)28-14-29-24/h8-14,16H,6-7H2,1-5H3,(H,28,29,30)/b15-8-,21-9+ |
| InChIKey | HYDSLUFTVAPWCR-CVTXJHAVSA-N |
| XLogP | 6.38 |
| TPSA | 72.82 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.59 |
| LogP ≤ 5 | 6.38 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155728761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.